000 | 01835 a2200469 4500 | ||
---|---|---|---|
005 | 20250517033050.0 | ||
264 | 0 | _c20160512 | |
008 | 201605s 0 0 eng d | ||
022 | _a1476-5381 | ||
024 | 7 |
_a10.1111/bph.13189 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTo, Kenneth K W | |
245 | 0 | 0 |
_aPelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cAug 2015 |
||
300 |
_a4089-106 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B _xgenetics |
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily G, Member 2 |
650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xgenetics |
650 | 0 | 4 |
_aAdenosine Triphosphatases _xmetabolism |
650 | 0 | 4 |
_aAminoquinolines _xpharmacology |
650 | 0 | 4 |
_aAniline Compounds _xpharmacology |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHyperthermia, Induced |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xgenetics |
650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aTopotecan _xpharmacology |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
700 | 1 | _aPoon, Daniel C | |
700 | 1 | _aWei, Yuming | |
700 | 1 | _aWang, Fang | |
700 | 1 | _aLin, Ge | |
700 | 1 | _aFu, Liwu | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 172 _gno. 16 _gp. 4089-106 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.13189 _zAvailable from publisher's website |
999 |
_c24914908 _d24914908 |